RESUMEN
BACKGROUND: We evaluated the efficacy and toxicity of docetaxel plus cisplatin combination as first-line chemotherapy for advanced gastric cancer. METHODS: Patients with metastatic or recurrent gastric adenocarcinoma, performance score Asunto(s)
Humanos
, Adenocarcinoma
, Cisplatino
, Quimioterapia
, Quimioterapia Combinada
, Neutropenia Febril
, Neutropenia
, Neoplasias Gástricas